Transforming Supportive Oncology Care: Innovative Skin-Directed Targeted Therapies for EGFR Inhibitor Induced Inflammation
Time: 11:30 am
day: Day Two AM
Details:
- First-in-Class Skin-Directed Prevention — blocking EGFRi on-target toxicities before skin inflammation occurs.
- Follicular-Focused Drug Delivery — maximizing local efficacy while minimizing systemic exposure.
- Targeting Rare Dermatologic Diseases — addressing high unmet medical need with limited treatment options.
